Tianshan Bio
3003137.853.56% ( +0.27 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Tianshan Bio(300313) the Revenue is 118.57 M (+381.1%);the EBIT is 4.544 M (+358.3%);the EPS is 0.0174 (+210.1%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.12B381.05%
----
----
EBIT
0.00B358.29%
----
----
EPS
0.0174210.13%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf